Holen Sie sich die Stockscreener-App
1.08
1.76%
0.0187
Handel nachbörslich:
1.09
0.01
+0.93%
Schlusskurs vom Vortag:
$1.0613
Offen:
$1.07
24-Stunden-Volumen:
14,548
Relative Volume:
0.38
Marktkapitalisierung:
$12.50M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.0377
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-1.82%
1M Leistung:
-8.47%
6M Leistung:
+8.00%
1J Leistung:
-37.57%
1-Tages-Spanne:
$1.07
$1.10
1-Wochen-Bereich:
$1.055
$1.13
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.08 | 12.28M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
149.02 | 65.30B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 45.60B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.42 | 18.78B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
300.43 | 13.64B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Market reaction to TherapeuticsMD Inc.’s recent newsAI Trade Signal Forecast with Chart Logic - Newser
Regression analysis insights on TherapeuticsMD Inc. performanceStable Swing Setup with Safety Analysis - Newser
Published on: 2025-08-11 03:11:11 - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersWeekly Market Direction and Sector Summary - Newser
Can volume confirm reversal in TherapeuticsMD Inc.Growth Summary Based on Market Positioning - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutLow Drawdown Stock Screener with Analysis - Newser
Published on: 2025-08-11 00:15:37 - Newser
How TherapeuticsMD Inc. stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
Developing predictive dashboards with TherapeuticsMD Inc. dataBuy List With Technical Entry Triggers - Newser
What recovery options are there for TherapeuticsMD Inc.Free High Growth Low Risk Stock Selection - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysTrend Confirmation Scanner with Entry Focus - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningStable Swing Setup with Safety Analysis - Newser
Is TherapeuticsMD Inc. stock bottoming outShort-Term Price Breakout Signal Analysis - Newser
Therapeuticsmd TXMD 2025Q2 Earnings Preview Upside Potential on New Product Launch - AInvest
What makes TherapeuticsMD Inc. stock price move sharplyFree High Conviction Intraday Stock Signals - Newser
Tools to monitor TherapeuticsMD Inc. recovery probabilityROI Focused Watchlist with Trade Confidence - Newser
Why TherapeuticsMD Inc. is moving todayInvestment Position Summary with Timeframe Forecast - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Investment Timeline and ROI Summary Report - Newser
TherapeuticsMD (NASDAQ:TXMD) Stock Price Up 0.5% – Should You Buy? - Defense World
How to interpret RSI for TherapeuticsMD Inc. stockStock Forecast Tools for Retail Traders - Newser
Will TherapeuticsMD Inc. rebound enough to break evenFree High Yield Stock Screening Results - Newser
TherapeuticsMD Inc. stock trend forecastTechnical Setup Guide for Daily Watchlist - Newser
Will TherapeuticsMD Inc. see short term momentumDaily Breakout List with Smart Filters - Newser
TherapeuticsMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTechnical Confirmation System with Signal Alerts - Newser
Traders Watching For Reversal Pattern in TherapeuticsMD Inc.Intraday Trade Ideas - beatles.ru
What is TherapeuticsMD Inc. company’s growth strategyGet alerts on the hottest stocks daily - Jammu Links News
What are analysts’ price targets for TherapeuticsMD Inc. in the next 12 monthsBuild wealth faster with high-performing stocks - Jammu Links News
What catalysts could drive TherapeuticsMD Inc. stock higher in 2025Unlock powerful trading tools for investors - Jammu Links News
What is the dividend policy of TherapeuticsMD Inc. stockDiscover market opportunities with expert help - Jammu Links News
TherapeuticsMD Inc. Stock Analysis and ForecastBuild wealth steadily with proven methods - Jammu Links News
Is TherapeuticsMD Inc. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - Jammu Links News
Evaluating TherapeuticsMD Inc. with trendline analysisFree Consistent Gain Investment Strategies - newser.com
What is the risk reward ratio of investing in TherapeuticsMD Inc. stockDiscover stock picks with superior returns - Jammu Links News
Should I hold or sell TherapeuticsMD Inc. stock in 2025Breakthrough profits - Jammu Links News
Custom watchlist performance reports with TherapeuticsMD Inc.Weekly High Conviction Trade Setup Analysis - newser.com
Is it the right time to buy TherapeuticsMD Inc. stockBuild wealth faster with disciplined trading - Jammu Links News
When is TherapeuticsMD Inc. stock expected to show significant growthUnstoppable profit momentum - Jammu Links News
Published on: 2025-08-03 15:41:04 - Jammu Links News
Is TherapeuticsMD Inc. a growth stock or a value stockDynamic portfolio growth - Jammu Links News
How does TherapeuticsMD Inc. compare to its industry peersUnlock exclusive trading strategies - Jammu Links News
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
2.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):